Midwest Institute for Clinical Research

Indianapolis, Indiana 46260

Use our guide to learn which trials are right for you!

We've found
5 trials
at this facility
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Non-Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial
A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.
Status: Enrolling, Phase II
Updated: 12/31/1969
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling, Phase II
Updated: 10/8/2015
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Resistant Hypertension Clinical Trial
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety
Status: Enrolling, Phase III
Updated: 12/31/1969
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Mild Hypertension Clinical Trial
A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx, an Antisense Inhibitor Administered Subcutaneously to Hypertensive Subjects With Controlled Blood Pressure
Status: Enrolling, Phase II
Updated: 12/31/1969
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials